The Filing Desk

Exelixis vs Fortrea

Exelixis EXEL · Fortrea FTRE · Biotechnology

Fortrea reported revenue of $2.7 billion in fiscal 2025, 1.2 times Exelixis' $2.3 billion in fiscal 2025. Exelixis' revenue grew 7.0% in its latest year, and Fortrea's grew 1.0%. Exelixis had an operating margin of 37.6%, against -32.0% at Fortrea. Free cash flow was $876 million at Exelixis and $88 million at Fortrea. Their fiscal years end in different months (January 2 and December 31), so the periods don't line up exactly.

Side by side

ExelixisFortrea
Latest fiscal yearFY2025, Jan 2, 2026FY2025, Dec 31, 2025
Revenue$2.3B$2.7B
Revenue growth7.0%1.0%
Revenue growth a year, last 5 years18.6%—
Gross margin96.4%—
Operating margin37.6%−32.0%
Net margin33.7%−36.2%
Free cash flow$876M$88M
Free cash flow margin37.8%3.2%
Return on capital64.9%−36.2%
Net debt to EBITDA−1.2x—
Dividends and buybacks$948M$0M
Change in diluted share count−4.8%—
Last close$65.11$23.83
P/E at the last close20.5×—
Insider trades, last 12 monthsbought $1.2 million, sold $42.2 millionsold $4.6 million
Piotroski F-score6 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ExelixisFortrea
Operating margin
Percent of revenue
ExelixisFortrea
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ExelixisFortrea

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Exelixis and Fortrea pages.